Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04451863 · ClinicalTrials.gov registry record · Phase 1

Analgesic and Subjective Effects of Terpenes

A Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

Active
Registry status
Phase 1
Development phase
45
Enrollment target
1
Study location

NCT04451863: Active Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

NCT04451863 is a Phase 1 study of Pain and Abuse, Drug that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 45 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04451863, a Phase 1 study of Pain and Abuse, Drug, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.

Conditions Studied

Interventions

  • DRUG Low THC
  • DRUG High THC
  • DRUG Low Myrcene
  • DRUG High Myrcene
  • DRUG Low Beta-Caryophyllene

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-12-15
Est. Completion 2026-04-30
Phase Phase 1

What the Registry Record Tells You About NCT04451863

The ClinicalTrials.gov registry entry for NCT04451863 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Low THC is the first listed.

NCT04451863 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04451863 about?

NCT04451863 is a clinical study titled "Analgesic and Subjective Effects of Terpenes". The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.

What is the current status of trial NCT04451863?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2021-12-15. Estimated completion is 2026-04-30.

What conditions does trial NCT04451863 study?

This clinical trial studies the following conditions: Pain, Abuse, Drug.

What interventions are being tested in trial NCT04451863?

The interventions under investigation include: Low THC (DRUG), High THC (DRUG), Low Myrcene (DRUG), High Myrcene (DRUG), Low Beta-Caryophyllene (DRUG).

Who is sponsoring clinical trial NCT04451863?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04451863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.